Wuhan Huakang Century Medical Co., Ltd.

SZSE:301235 Stock Report

Market Cap: CN¥2.0b

Wuhan Huakang Century Medical Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Xinqiang Xie

Chief executive officer

CN¥642.1k

Total compensation

CEO salary percentagen/a
CEO tenure5.2yrs
CEO ownershipn/a
Management average tenure5.2yrs
Board average tenure2.2yrs

Recent management updates

Recent updates

Earnings Troubles May Signal Larger Issues for Wuhan Huakang Century Medical (SZSE:301235) Shareholders

Nov 06
Earnings Troubles May Signal Larger Issues for Wuhan Huakang Century Medical (SZSE:301235) Shareholders

Wuhan Huakang Century Medical's (SZSE:301235) Anemic Earnings Might Be Worse Than You Think

May 03
Wuhan Huakang Century Medical's (SZSE:301235) Anemic Earnings Might Be Worse Than You Think

Returns On Capital At Wuhan Huakang Century Medical (SZSE:301235) Have Hit The Brakes

Apr 17
Returns On Capital At Wuhan Huakang Century Medical (SZSE:301235) Have Hit The Brakes

CEO

Xinqiang Xie (59 yo)

5.2yrs

Tenure

CN¥642,100

Compensation

Mr. Xinqiang Xie is General Manager and Director of Wuhan Huakang Century Medical Co., Ltd. from November 28, 2019.


Leadership Team

NamePositionTenureCompensationOwnership
Xinqiang Xie
General Manager & Director5.2yrsCN¥642.10kno data
Yingchao Zhang
Financial Director & Accounting Supervisor5.2yrsCN¥582.80kno data
Amy Tam
Deputy GM & Director5.2yrsCN¥689.10kno data
Zhan Peng
Deputy GM & Secretary1.8yrsCN¥504.50kno data
Hai Wang
Deputy General Manager5.2yrsCN¥625.80kno data
Jiali Wang
Deputy General Manager5.2yrsCN¥586.80kno data

5.2yrs

Average Tenure

45.5yo

Average Age

Experienced Management: 301235's management team is seasoned and experienced (5.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Xinqiang Xie
General Manager & Director5.2yrsCN¥642.10kno data
Amy Tam
Deputy GM & Director5.2yrsCN¥689.10kno data
Pingtao Tan
Chairman of the Board5.2yrsCN¥651.30k47.19%
CN¥ 953.3m
Liang Yu
Independent Director5.2yrsCN¥70.00kno data
Menghuan Guo
Independent Director2.2yrsCN¥70.00kno data
Liang Qi
Independent Director2.2yrsCN¥70.00kno data
Wenjie Cheng
Non-Employee Supervisor2.2yrsno datano data
Chenglin Zhou
Non-Employee Supervisor2.2yrsno datano data
Huyang Peng
Chairman of the Supervisory Board2.2yrsno datano data

2.2yrs

Average Tenure

43yo

Average Age

Experienced Board: 301235's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/24 18:21
End of Day Share Price 2025/01/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Wuhan Huakang Century Medical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution